FEMCON FE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Femcon Fe, and when can generic versions of Femcon Fe launch?
Femcon Fe is a drug marketed by Apil and is included in one NDA.
The generic ingredient in FEMCON FE is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for FEMCON FE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Clinical Trials: | 1 |
| Patent Applications: | 166 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FEMCON FE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FEMCON FE |
| What excipients (inactive ingredients) are in FEMCON FE? | FEMCON FE excipients list |
| DailyMed Link: | FEMCON FE at DailyMed |
Recent Clinical Trials for FEMCON FE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Teva Pharmaceuticals USA | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for FEMCON FE
US Patents and Regulatory Information for FEMCON FE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apil | FEMCON FE | ethinyl estradiol; norethindrone | TABLET;ORAL | 021490-001 | Nov 14, 2003 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FEMCON FE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Apil | FEMCON FE | ethinyl estradiol; norethindrone | TABLET;ORAL | 021490-001 | Nov 14, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
